resveratrol has been researched along with Animal Mammary Carcinoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
He, W; Ju, J; Li, C; Wang, Y; Wu, Y; Xu, Y; Zhang, J; Zhang, Y | 1 |
Biragyn, A; Bodogai, M; de Cabo, R; Lee-Chang, C; Martin-Montalvo, A; Moaddel, R; Sanghvi, M; Wejksza, K | 1 |
Bobrowska-Korczak, B; Skrajnowska, D; Tokarz, A | 1 |
Borst, P; Gonggrijp, M; Jonkers, J; Kersbergen, A; Rottenberg, S; Sol, W; van de Wetering, K; Zander, SA | 1 |
Bartozzi, B; Di Stasio, G; Donnini, A; Orlando, F; Provinciali, M; Re, F; Smorlesi, A | 1 |
Csordas, A; Galfi, P; Jakus, J; Molnar, T; Neogrady, S | 1 |
6 other study(ies) available for resveratrol and Animal Mammary Carcinoma
Article | Year |
---|---|
The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice.
Topics: Animals; Curcumin; Immunosuppression Therapy; Immunosuppressive Agents; Mammary Neoplasms, Animal; Mice; Quercetin; Reactive Oxygen Species; Resveratrol; Tumor Microenvironment | 2023 |
Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.
Topics: Animals; B-Lymphocytes, Regulatory; Female; Forkhead Transcription Factors; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Resveratrol; STAT3 Transcription Factor; Stilbenes; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2013 |
The effect of dietary zinc--and polyphenols intake on DMBA-induced mammary tumorigenesis in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antimutagenic Agents; Carcinogens; Dietary Supplements; Female; Genistein; Mammary Neoplasms, Animal; Polyphenols; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Zinc | 2012 |
Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.
Topics: Animals; Antioxidants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; BRCA1 Protein; Female; Genistein; Mammary Neoplasms, Animal; Mice; Mice, Knockout; Ovariectomy; Phytoestrogens; Resveratrol; Stilbenes; Survival Rate; Tumor Suppressor Protein p53 | 2012 |
Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Lung; Lymphocytes; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Neoplasm Metastasis; Receptor, ErbB-2; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Spleen; Stilbenes; Time Factors | 2005 |
Divergent effects of resveratrol, a polyphenolic phytostilbene, on free radical levels and type of cell death induced by the histone deacetylase inhibitors butyrate and trichostatin A.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Butyrates; Cell Death; Cell Line, Tumor; Enzyme Inhibitors; Female; Free Radicals; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Intestinal Mucosa; Kinetics; Mammary Neoplasms, Animal; Mice; Necrosis; Resveratrol; Stilbenes | 2005 |